Jinyu Bio-Technology Co Ltd
SSE:600201
Jinyu Bio-Technology Co Ltd
Cash from Operating Activities
Jinyu Bio-Technology Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
J
|
Jinyu Bio-Technology Co Ltd
SSE:600201
|
Cash from Operating Activities
¥429.3m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
3%
|
Beigene Ltd
HKEX:6160
|
Cash from Operating Activities
-¥7.8B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Operating Activities
-¥1.7B
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Operating Activities
¥1.5B
|
CAGR 3-Years
49%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Cash from Operating Activities
¥2.5B
|
CAGR 3-Years
37%
|
CAGR 5-Years
55%
|
CAGR 10-Years
34%
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Operating Activities
¥3.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
106%
|
CAGR 10-Years
47%
|
See Also
What is Jinyu Bio-Technology Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
429.3m
CNY
Based on the financial report for Sep 30, 2023, Jinyu Bio-Technology Co Ltd's Cash from Operating Activities amounts to 429.3m CNY.
What is Jinyu Bio-Technology Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
3%
Over the last year, the Cash from Operating Activities growth was -12%. The average annual Cash from Operating Activities growth rates for Jinyu Bio-Technology Co Ltd have been -14% over the past three years , -7% over the past five years , and 3% over the past ten years .